arrow
Back
T

Thomas S. Dexheimer

national institutes of health (nih) - usa

39H-index
287Paper Count
4.9KCitation Count
Published Papers 77
Publication Date
High-throughput combination screening of Pidnarulex and other G-quadruplex ligands in multi-cell type tumor spheroids
err2025-10-21
err0
errOAAI
errThomas S. Dexheimer; Nathan P. Coussens; Thomas Silvers; Poorva Juneja; Eric Jones; Steven D. Gore; Mark W. Kunkel; James H. Doroshow; Beverly A. Teicher
errShare
errSave
RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types
err2025-10-01
err0
errOAAI
errDavoudi, Zahra; Dexheimer, Thomas S.; Coussens, Nathan P.; Silvers, Thomas; Fox, Raymond G.; Kemp, Samantha B.; Juneja, Poorva; Morris, Joel; Hollingshead, Melinda G.; Takebe, Naoko; Doroshow, James H.; Teicher, Beverly A.
errShare
errSave
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroids
err2025-09-12
err0
errOAAI
errBeverly A. Teicher; Thomas S. Dexheimer; Thomas Silvers; Nathan P. Coussens; Eric Jones; Steven D. Gore; Mark Kunkel; James H. Doroshow
errShare
errSave
Polymerase Ѳ inhibitors combinations with approved and investigational agents in patient-derived tumor multi-cell type (mct) spheroids
err2025-06-27
err0
errOAAI
errBeverly A. Teicher; Thomas S. Dexheimer; Li Chen; Thomas Silvers; Eric M. Jones; Nathan P. Coussens; J. Paul Eder; James H. Doroshow
errShare
errSave
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids
err2025-06-01
err0
errOAAI
errCoussens, Nathan P.; Dexheimer, Thomas S.; Silvers, Thomas; Sanchez, Phillip R.; Chen, Li; Hollingshead, Melinda G.; Takebe, Naoko; Doroshow, James H.; Teicher, Beverly A.
errShare
errSave
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids
err2025-02-01
err0
errOAAI
errDexheimer, Thomas S.; Davoudi, Zahra; Coussens, Nathan P.; Silvers, Thomas; Morris, Joel; Takebe, Naoko; Said, Rabih; Moscow, Jeffrey A.; Doroshow, James H.; Teicher, Beverly A.
errShare
errSave
HTS384 NCI60: The Next Phase of the NCI60 Screen
err2024-06-11
err2
errOAAI
errKunkel, Mark W.; Coussens, Nathan P.; Morris, Joel; Taylor, Ronald C.; Dexheimer, Thomas S.; Jones, Eric M.; Doroshow, James H.; Teicher, Beverly A.
errShare
errSave
Development and performance of the National Cancer Institute's HTS384 NCI60 screen: A modernized platform to support drug discovery and development by the worldwide cancer research community
err2024-03-22
err0
PREAI
errCoussens, Nathan P.; Dexheimer, Thomas S.; Jones, Eric M.; Silvers, Thomas; Britt, John R.; Taylor, Ronald C.; Kunkel, Mark W.; Doroshow, James H.; Teicher, Beverly A.
errShare
errSave
Combinations of Cdc-like kinase (CLK) inhibitors with targeted oncology agents or standard chemotherapy in patient-derived multi-cell type tumor spheroids
err2024-03-22
err0
PREAI
errDexheimer, Thomas Steven; Silvers, Thomas; Coussens, Nathan P.; Gore, Steven D.; Doroshow, James H.; Teicher, Beverly A.
errShare
errSave
NCI60 HTS384: The next phase of the NCI60 screen
err2023-12-01
err0
PREAI
errTeicher, Beverly A.; Kunkel, Mark W.; Morris, Joel; Taylor, Ronald C.; Dexheimer, Thomas S.; Coussens, Nathan P.; Doroshow, James H.
errShare
errSave
Combinations of PI3K inhibitors with targeted oncology agents in multicellular spheroid models
err2023-12-01
err0
PREAI
errDexheimer, Thomas S.; Silvers, Thomas; Coussens, Nathan P.; Said, Rabih; Teicher, Beverly A.; Doroshow, James H.
errShare
errSave
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based Resource
err2023-08-07
err5
errOAAI
errMorris, Joel; Kunkel, Mark W.; White, Stephen L.; Wishka, Donn G.; Lopez, Omar D.; Bowles, Lori; Brady, Penny Sellers; Ramsey, Patricia; Grams, Julie; Rohrer, Tiffany; Martin, Karen; Dexheimer, Thomas S.; Coussens, Nathan P.; Evans, David; Risbood, Prabhakar; Sonkin, Dmitriy; Williams, John D.; Polley, Eric C.; Collins, Jerry M.; Doroshow, James H.; Teicher, Beverly A.
errShare
errSave
errShare
errSave
Development of a Cell-Based AlphaLISA Assay for High-Throughput Screening for Small Molecule Proteasome Modulators
err2023-04-21
err4
errOAAI
errStaerz, Sophia D.; Lisabeth, Erika M.; Njomen, Evert; Dexheimer, Thomas S.; Neubig, Richard R.; Tepe, Jetze J.
errShare
errSave
Biochemical inhibition profiles of 370 wild type human kinases provide a basis for selecting alternative combinations of EGFR and VEGFR inhibitors
err2023-04-04
err0
PREAI
errCoussens, Nathan P.; Dexheimer, Thomas S.; Silvers, Thomas; Uzelac, Shannon; Georgius, Kyle; Carter, John; Shearer, Tia; Rao, Rekha; Gray, Karen; Srivastava, Apurva K.; Kinders, Robert J.; Evrard, Yvonne A.; Hollingshead, Melinda G.; Morris, Joel; Moscow, Jeffrey A.; Parchment, Ralph E.; Teicher, Beverly A.; Doroshow, James H.
errShare
errSave
Combination therapies in matched 3D in vitro and in vivo preclinical models of rare and recalcitrant cancers from the National Cancer Institute's Patient-Derived Models Repository
err2023-04-04
err0
PREAI
errDexheimer, Thomas S.; Silvers, Thomas; Delosh, Rene; Reinhart, Russell; Ogle, Chad; Davoudi, Zahra; Jones, Eric; Trail, Debbie; Carter, John; Mills, Justine; Georgius, Kyle; Stotler, Howard; Norris, Michelle; Uzelac, Shannon; Borgel, Suzanne; Minor, Tiffanie; Stockwin, Luke; Mullendore, Michael; Plater, Kevin; Kalmbach, Keegan; Steed, Jessica; Murphy, Matthew; Bliss, Gareth; Bonomi, Carrie; Dougherty, Kelly; Gibson, Marion; Cooper, Kevin; Newton, Dianne; Timme, Cindy R.; Evrard, Yvonne A.; Hollingshead, Melinda G.; Coussens, Nathan P.; Parchment, Ralph E.; Doroshow, James H.; Teicher, Beverly A.
errShare
errSave
Advancing a screening platform with panels of patient-derived organoid models for drug discovery and development
err2023-04-04
err0
PREAI
errRapisarda, Annamaria; Jones, Eric; Hose, Curtis; Harris, Erik; Campbell, Petreena S.; Ortiz, Mariaestela; Connelly, John; Mahashetty, Nanda; Silvers, Thomas; Davoudi, Zahra; Brady, Penny Sellers; Rohrer, Tiffany Nikirk; Grams, Julie; Martin, Karen; Ramsey, Patricia; Bowles, Lori; Britt, John R.; Parchment, Ralph E.; Dexheimer, Thomas S.; Teicher, Beverly A.; Doroshow, James H.; Coussens, Nathan P.
errShare
errSave
Targeted investigational oncology agents (IOA) in the NCI60: a phenotypic systems-based resource
err2023-04-04
err0
PREAI
errMorris, Joel; Kunkel, Mark W.; White, Stephen L.; Wishka, Donn G.; Lopez, Omar D.; Bowles, Lori; Sellers, Penny; Ramsey, Patricia; Grams, Julie; Rohrer, Tiffany; Martin, Karen; Dexheimer, Thomas; Sonkin, Dmitriy; Williams, John D.; Collins, Jerry M.; Doroshow, James H.; Teicher, Beverly A.
errShare
errSave
Aryl-hydrocarbon receptor inhibitors in combination with anticancer agents, especially proteasome pathway inhibitors, in a complex spheroid screen using patient-derived cell lines can result in greater-than additive cytotoxicity
err2023-04-04
err0
PREAI
errTeicher, Beverly A.; Moscow, Jeffrey A.; Morris, Joel; Doroshow, James H.; Dexheimer, Thomas S.; Coussens, Nathan P.; Silvers, Thomas; Delosh, Rene; Davoudi, Zahra; Reinhart, Russel; Ogle, Chad; Jones, Eric
errShare
errSave